Arcadia Biosciences
RKDA
14 hedge funds and large institutions have $259K invested in Arcadia Biosciences in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
17% more capital invested
Capital invested by funds: $222K → $259K (+$37K)
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
1.25% less ownership
Funds ownership: 5.58% → 4.33% (-1.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.84K |
| 2 |
Morgan Stanley
New York
|
+$707 |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$296 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mariner
Overland Park,
Kansas
|
-$51.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$23.8K |
| 3 |
LFG
Larson Financial Group
St Louis,
Missouri
|
-$3 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Mariner
Overland Park,
Kansas
| $62.5K | -$51.3K | -12,981 | -47% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $61.9K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $56.4K | – | – | – |
|
4
State Street
Boston,
Massachusetts
| $53.6K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $11K | -$23.8K | -6,016 | -70% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $8.25K | +$5.84K | +1,478 | +338% |
|
|
7
Morgan Stanley
New York
| $3.39K | +$707 | +179 | +29% |
|
|
AWM
8
Atticus Wealth Management
Palm Beach Gardens,
Florida
| $1.17K | – | – | – |
|
|
SS
9
SBI Securities
Tokyo,
Japan
| $517 | – | – | – |
|
|
10
Osaic Holdings
Scottsdale,
Arizona
| $323 | +$296 | +75 | New |
|
11
Group One Trading
Chicago,
Illinois
| $79 | – | – | – |
|
|
12
Bank of America
Charlotte,
North Carolina
| $56 | +$8 | +2 | +18% |
|
13
AssetMark Inc
Concord,
California
| $22 | – | – | – |
|
|
HI
14
Harbour Investments
Madison,
Wisconsin
| $4 | – | – | – |
|
|
LFG
15
Larson Financial Group
St Louis,
Missouri
| – | -$3 | -1 | Closed |
|
RKDA Hedge Fund Activity: Q2 2025 in Review
14 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q2 2025, worth a combined $259K — up 17% from $222K a quarter earlier.
Fund positioning in RKDA was balanced in Q2 2025: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was Tower Research Capital (TRC), adding an estimated $5.84K. The largest seller was Mariner, cutting an estimated $51.3K.
- 14 institutional investors held Arcadia Biosciences (RKDA) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $259K of Arcadia Biosciences stock for Q2 2025, up 17% quarter-over-quarter.
- 1 fund opened new Arcadia Biosciences positions in Q2 2025 and 1 closed out, a net change of 0 holders.
- The largest Arcadia Biosciences buyer in Q2 2025 was Tower Research Capital (TRC), an estimated $5.84K added.
- The largest Arcadia Biosciences seller in Q2 2025 was Mariner, an estimated $51.3K sold.
Based on aggregated 13F filings for Q2 2025.